Resolution of in flammation: state of the art, definitions and terms
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
A recent focus meeting on Controlling Acute Inflammation was held in London, April 27–28, 2006, organized by D.W. Gilroy and S.D. Brain for the British Pharmacology Society. We concluded at the meeting that a consensus report was needed that addresses the rapid progress in this emerging field and details how the specific study of resolution of acute inflammation provides leads for novel anti‐inflammatory therapeutics, as well as defines the terms and key components of interest in the resolution process within tissues as appreciated today. The inflammatory response protects the body against infection and injury but can itself become dysregulated with deleterious consequences to the host. It is now evident that endogenous biochemical pathways activated during defense reactions can counter‐regulate inflammation and promote resolution. Hence, resolution is an active rather than a passive process, as once believed, which now promises novel approaches for the treatment of inflammation‐associated diseases based on endogenous agonists of resolution.—Serhan, C. N., Brain, S. D., Buckley, C. D., Gilroy, D. W., Haslett, C., O'Neill, L. A. J., Perretti, M., Rossi, A. G., Wallace, J. L. Resolution of inflammation: state of the art, definitions and terms. FASEB J. 21, 325–332 (2007)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These lipid mediators can selectively stop neutrophil infiltration; increase monocyte recruitment and macrophage phagocytosis; stimulate the expression of genes important for antimicrobial defense; and promote the exit of phagocytes from the inflamed sites [100–103].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [103]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These lipid mediators can selectively stop neutrophil infiltration; increase monocyte recruitment and macrophage phagocytosis; stimulate the expression of genes important for antimicrobial defense; and promote the exit of phagocytes from the inflamed sites [100–103].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [103]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These lipid mediators can selectively stop neutrophil infiltration; increase monocyte recruitment and macrophage phagocytosis; stimulate the expression of genes important for antimicrobial defense; and promote the exit of phagocytes from the inflamed sites [100–103].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [103]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The process of inflammation resolution involves not only passive mechanisms, e.g., dissipation of chemotactic gradient or initial danger signals, but also active biochemical pathways [103].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [103]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“These lipid mediators can selectively stop neutrophil infiltration; increase monocyte recruitment and macrophage phagocytosis; stimulate the expression of genes important for antimicrobial defense; and promote the exit of phagocytes from the inflamed sites [100–103].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [103]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326 · cited 3×
“TLRs and NLRs also sense products of inflamed tissue, and notable examples are the sensing of low MW hyaluronic acid fragments by TLR2 and TLR4 (13) and the sensing of uric acid by Nalp3 (14).”
Background(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-3-460_4 · Cited by 4,529
Resolution of inflammation: the beginning programs the end
Serhan, C. N., & Savill, J. (2005) · Nature Immunology · doi:10.1038/ni1276 · Cited by 2,552 · cited 2×
“1C), may lead to prolonged inflammation and the inability for the tissue to return to homeostasis (26) and complete the full life-cycle per se of the neutrophils and mononuclear cells recruited to the tissue.”
BackgroundSelf-citationAgostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N., & Tschopp, J. (2004) · Immunity · doi:10.1016/s1074-7613(04)00046-9 · Cited by 1,768 · cited 1×
“Nalp3 occurs in an inflammasome complex with caspase-1, ASC, cardinal, and Nalp2 ( 12 ).”
BackgroundMolecular identification of a danger signal that alerts the immune system to dying cells
Shi, Y., Evans, J. E., & Rock, K. L. (2003) · Nature · doi:10.1038/nature01991 · Cited by 1,684 · cited 1×
“Uric acid is the causative agent of gout but is also released by damaged cells, possibly as a general signal for inflammation (15).”
BackgroundSerhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., & Moussignac, R.-L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020760 · Cited by 1,650 · cited 1×
“Additionally, the widely used aspirin jump-starts resolution by making up for its loss in prostaglandin production, which plays key roles in resolution, by instead generating the epimeric version of lipid mediators (25), such as the aspirin-triggered lipoxins (recently reviewed in ref.”
BackgroundSelf-citationNegative regulation of Toll-like receptor-mediated immune responses
Liew, F. Y., Xu, D., Brint, E. K., & O'Neill, L. A. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1630 · Cited by 1,509 · cited 8×
“In effect, TLRs sow the seeds of their own destruction, and the role of negative regulators clearly indicates how robust the TLR system is.”
BackgroundInfluentialSelf-citationLipid mediator class switching during acute inflammation: signals in resolution
Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K., & Serhan, C. N. (2001) · Nature Immunology · doi:10.1038/89759 · Cited by 1,453 · cited 1×
“enzymes are expressed (31), and whether it is resolving”
BackgroundSelf-citationRegulation of lung injury and repair by Toll-like receptors and hyaluronan
Jiang, D., Liang, J., Fan, J., Yu, S., Chen, S., Luo, Y., Prestwich, G. D., Mascarenhas, M. M., Garg, H. G., Quinn, D. A., et al. (2005) · Nature Medicine · doi:10.1038/nm1315 · Cited by 1,401 · cited 4×
“TLRs and NLRs also sense products of inflamed tissue, and notable examples are the sensing of low MW hyaluronic acid fragments by TLR2 and TLR4 (13) and the sensing of uric acid by Nalp3 (14).”
BackgroundInfluentialInducible cyclooxygenase may have anti-inflammatory properties
Gilroy, D. W., Colville-Nash, P. R., Willis, D., Chivers, J., Paul-Clark, M. J., & Willoughby, D. A. (1999) · Nature Medicine · doi:10.1038/9550 · Cited by 1,242
Self-citation
Cited by
Items 101–200 of 1,000
Oral Inflammatory Diseases and Systemic Inflammation: Role of the Macrophage
Hasturk, H., Kantarci, A., & Van Dyke, T. E. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00118 · Cited by 212
“The efforts to control inflammation process has been mainly with the use of pharmacologic agents, which act as antagonists for some of the mediators of inflammation (Serhan et al., 2007).”
BackgroundHydrogen sulfide and nitric oxide interactions in inflammation
Lo Faro, M. L., Fox, B., Whatmore, J. L., Winyard, P. G., & Whiteman, M. (2014) · Nitric Oxide · doi:10.1016/j.niox.2014.05.014 · Cited by 202
“IL-10 and lipoxins) which are responsible for the resolution of inflammation (21, 25).”
BackgroundAnalysing the eosinophil cationic protein - a clue to the function of the eosinophil granulocyte
Bystrom, J., Amin, K., & Bishop-Bailey, D. (2011) · Respiratory Research · doi:10.1186/1465-9921-12-10 · Cited by 209
“In murine system eosinophils have been ascribed a novel role in inflammation; the cells enter and contribute to the well orchestrated process of inflammation resolution of by release of the pro-resolving lipid protectin D1 [154] (for a review see [155]).”
BackgroundBlame the signaling: Role of cAMP for the resolution of inflammation
Tavares, L. P., Negreiros-Lima, G. L., Lima, K. M., E Silva, P. M. R., Pinho, V., Teixeira, M. M., & Sousa, L. P. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105030 · Cited by 205
Whelan, J. (2009) · The Journal of Nutrition · doi:10.3945/jn.108.094268 · Cited by 206
“Furthermore, they appear to be important in the resolution of the inflammatory response via the formation of the newly discovered E and D series resolvins (56,57).”
Background15-Epi-lipoxin A 4 Inhibits Myeloperoxidase Signaling and Enhances Resolution of Acute Lung Injury
El Kebir, D., József, L., Pan, W., Wang, L., Petasis, N. A., Serhan, C. N., & Filep, J. G. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200810-1601oc · Cited by 205
“15-Epi-LXA4 is believed to promote recruitment of monocytes in a nonphlogistic fashion, consistent with facilitation of tissue repair (5, 22, 48).”
BackgroundSelf-citationHo, K. J., Spite, M., Owens, C. D., Lancero, H., Kroemer, A. H. K., Pande, R., Creager, M. A., Serhan, C. N., & Conte, M. S. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.091082 · Cited by 204
Self-citationProresolution Therapy for the Treatment of Delayed Healing of Diabetic Wounds
Tang, Y., Zhang, M. J., Hellmann, J., Kosuri, M., Bhatnagar, A., & Spite, M. (2013) · Diabetes · doi:10.2337/db12-0684 · Cited by 204
“The resolution of inflammation is accomplished by time- and site-specific generation of proresolving mediators that control both the magnitude and the duration of the inflammatory response (7,9).”
BackgroundKain, V., Prabhu, S. D., & Halade, G. V. (2014) · Basic Research in Cardiology · doi:10.1007/s00395-014-0444-7 · Cited by 199
Mediators of the Resolution of the Inflammatory Response
Sugimoto, M. A., Vago, J. P., Perretti, M., & Teixeira, M. M. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.01.007 · Cited by 199
Self-citationOral infections and cardiovascular disease
Kholy, K. E., Genco, R. J., & Van Dyke, T. E. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.03.001 · Cited by 197
The role of platelets in the recruitment of leukocytes during vascular disease
Ed Rainger, G., Chimen, M., Harrison, M. J., Yates, C. M., Harrison, P., Watson, S. P., Lordkipanidzé, M., & Nash, G. B. (2015) · Platelets · doi:10.3109/09537104.2015.1064881 · Cited by 194
“leukocyte recruitment might be established in disease states [18].”
BackgroundThe resolution of inflammation: the devil in the flask and in the details
Serhan, C. N. (2011) · The FASEB Journal · doi:10.1096/fj.11-0502ufm · Cited by 196
“Rigorous attention to cellular-molecular definitions, precise structure-activity relationships, and the use of tissue resolution indices (6, 69) can help to propel this area forward and open up a new appreciation of inflammation-associated disease mechanisms and potentially opportunities for designer therapeutics; for…”
ResultSelf-citationAlzheimer’s Disease, Oligomers, and Inflammation
Forloni, G., & Balducci, C. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170819 · Cited by 194
“response is terminated with removal of the stimulating pathogen, and the resolution is an active process regulated by specialized pro-resolving mediators [72, 73].”
BackgroundResolvin E2 Formation and Impact in Inflammation Resolution
Oh, S. F., Dona, M., Fredman, G., Krishnamoorthy, S., Irimia, D., & Serhan, C. N. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103652 · Cited by 189
“SPMs such as RvE2, as shown in the present report, are distinct chemical mediators in both limiting inflammation and promoting resolution, namely the SPM defining biological mechanism of action (42, 43).”
BackgroundSelf-citationVago, J. P., Nogueira, C. R. C., Tavares, L. P., Soriani, F. M., Lopes, F., Russo, R. C., Pinho, V., Teixeira, M. M., & Sousa, L. P. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0112008 · Cited by 189
“[5]).”
BackgroundChan, M. M.-Y., & Moore, A. R. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903816 · Cited by 183
Lipid Mediators in Inflammation
Bennett, M., & Gilroy, D. W. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0035-2016 · Cited by 172
“These pathways converge on the termination of acute inflammatory responses and contribute to the notion that chronic inflammation is avoided and wounds healed in an appropriate manner(329, 330).”
BackgroundSelf-citationEffects of inflammation on stem cells: together they strive?
Kizil, C., Kyritsis, N., & Brand, M. (2015) · EMBO reports · doi:10.15252/embr.201439702 · Cited by 178
“This tissue swelling is relinquished by the lymphatic system where antigens are recognized by the T and B cells of the adaptive immune system, which is a recent evolutionary invention in vertebrates [4].”
Mechanisms of Resolution of Inflammation: A Focus on Cardiovascular Disease
Maskrey, B. H., Megson, I. L., Whitfield, P. D., & Rossi, A. G. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.213850 · Cited by 177
Self-citationBoosting Inflammation Resolution in Atherosclerosis
Fredman, G., & Tabas, I. (2017) · The American Journal of Pathology · doi:10.1016/j.ajpath.2017.01.018 · Cited by 174
Pain-resolving immune mechanisms in neuropathic pain
Fiore, N. T., Debs, S. R., Hayes, J. P., Duffy, S. S., & Moalem-Taylor, G. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00777-3 · Cited by 172
Zhang, M. J., & Spite, M. (2012) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071811-150726 · Cited by 171
“The recognition that resolution of inflammation is an actively regulated process ignited an entirely new area of research and uncovered new endogenous lipid mediators that not only dampen the propagation of inflammation, but also actively signal the removal of microbes and dead tissue to allow for a return to homeosta…”
BackgroundMechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy
Wallace, J. L. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i12.1861 · Cited by 168
Self-citationWallace, J. L. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01509.x · Cited by 168
“15(R)-epi-lipoxin A4 and its epimer, lipoxin A4, are potent anti-inflammatory substances, suppressing neutrophil adherence to the endothelium (Claria and Serhan, 1995; Serhan and Oliw, 2001; Serhan et al., 2007).”
BackgroundSelf-citationThe Role of Neutrophils and Monocytes in Innate Immunity
Kantari, C., Pederzoli-Ribeil, M., & Witko-Sarsat, V. (2008) · Contributions to Microbiology · doi:10.1159/000136335 · Cited by 169
Elsharkawy, A. M., Oakley, F., Lin, F., Packham, G., Mann, D. A., & Mann, J. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.03.025 · Cited by 160
Fatty acid metabolism in the progression and resolution of CNS disorders
Bogie, J. F. J., Haidar, M., Kooij, G., & Hendriks, J. J. A. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.01.004 · Cited by 167
Vieira, A. T., Galvão, I., Macia, L. M., Sernaglia, É. M., Vinolo, M. A. R., Garcia, C. C., Tavares, L. P., Amaral, F. A., Sousa, L. P., Martins, F. S., et al. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a1015-453rrr · Cited by 163
“These results place acetate as a novel mediator of resolution of inflammation [26].”
BackgroundResolution of acute inflammation bridges the gap between innate and adaptive immunity
Newson, J., Stables, M., Karra, E., Arce-Vargas, F., Quezada, S., Motwani, M., Mack, M., Yona, S., Audzevich, T., & Gilroy, D. W. (2014) · Blood · doi:10.1182/blood-2014-03-562710 · Cited by 160
“This early onset phase is followed by phagocytosing macrophage (Mws) leading to leukocyte clearance and resolution.(1) Although research has traditionally focused on identifying factors that drive inflammation, emphasis has now shifted toward this latter phase of resolution to understand how immune-mediated responses…”
BackgroundSelf-citationFredman, G., & Serhan, C. N. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00984-x · Cited by 186
“Now, we appreciate that the termination (or resolution) of inflammation is an active, highly coordinated programme to control the magnitude and duration of inflammation and to stimulate tissue repair 15 .”
Self-citationFunctional muscle recovery with nanoparticle-directed M2 macrophage polarization in mice
Raimondo, T. M., & Mooney, D. J. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1806908115 · Cited by 156
The recent advances in scaffolds for integrated periodontal regeneration
Woo, H. N., Cho, Y. J., Tarafder, S., & Lee, C. H. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.03.012 · Cited by 212
The choroid plexus synergizes with immune cells during neuroinflammation
Xu, H., Lotfy, P., Gelb, S., Pragana, A., Hehnly, C., Byer, L. I. J., Shipley, F. B., Zawadzki, M. E., Cui, J., Deng, L., et al. (2024) · Cell · doi:10.1016/j.cell.2024.07.002 · Cited by 187
Anti-Inflammatory and Cytoprotective Actions of Hydrogen Sulfide: Translation to Therapeutics
Wallace, J. L., Blackler, R. W., Chan, M. V., Da Silva, G. J., Elsheikh, W., Flannigan, K. L., Gamaniek, I., Manko, A., Wang, L., Motta, J.-P., et al. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2014.5901 · Cited by 156
“This is consistent with the roles of H2S in maintaining mucosal integrity and in the resolution of inflammation, as COX-2-derived eicosanoids are crucial mediators of these processes (85, 94) (Fig.”
InfluentialSelf-citationSerum Metabolome and Lipidome Changes in Adult Patients with Primary Dengue Infection
Cui, L., Lee, Y. H., Kumar, Y., Xu, F., Lu, K., Ooi, E. E., Tannenbaum, S. R., & Ong, C. N. (2013) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0002373 · Cited by 156
“is an active process, as opposed to a passive one [41].”
BackgroundSchäppi, M. G., Jaquet, V., Belli, D. C., & Krause, K. (2008) · Seminars in Immunopathology · doi:10.1007/s00281-008-0119-2 · Cited by 171
“In particular, there is emerging evidence that the resolution of inflammation is an active process requiring the activation of endogenous programs (for review, see [148]).”
BackgroundYang, H.-Z., Wang, J.-P., Mi, S., Liu, H.-Z., Cui, B., Yan, H.-M., Yan, J., Li, Z., Liu, H., Hua, F., et al. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.09.019 · Cited by 155
“31,32 There are “contradictory” observations on the role of TLR4 activity in the regulation of inflammation and tissue fibrosis in a diversity of tissue injury models.”
BackgroundExploiting the Annexin A1 pathway for the development of novel anti‐inflammatory therapeutics
Perretti, M., & Dalli, J. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00483.x · Cited by 154
Self-citationInfection and inflammatory mechanisms
Dyke, T. E. V., & Winkelhoff, A. J. V. (2013) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.12088 · Cited by 188
Macrophage Targeted Theranostics as Personalized Nanomedicine Strategies for Inflammatory Diseases
Patel, S. K., & Janjic, J. M. (2014) · Theranostics · doi:10.7150/thno.9476 · Cited by 166
“[20] Aberrant or prolonged inflammation can produce significant endogenous tissue injury leading to several diseases.[21, 22] Macrophages are a major cellular component present in the inflammatory milieu.”
BackgroundHe, H., Zhang, S., Tighe, S., Son, J., & Tseng, S. C. G. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.479584 · Cited by 149
Recchiuti, A., & Serhan, C. N. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00298 · Cited by 149
“They can differentiate into macrophages (MΦs) and clear microbes, cellular debris, and apoptotic PMN by phagocytosis in a non-phlogistic process termed efferocytosis (Honn et al., 1989; Gordon, 2007; Serhan et al., 2007).”
Self-citationAspirin‐triggered resolvin D1 prevents surgery‐induced cognitive decline
Terrando, N., Gómez‐Galán, M., Yang, T., Carlström, M., Gustavsson, D., Harding, R. E., Lindskog, M., & Eriksson, L. I. (2013) · The FASEB Journal · doi:10.1096/fj.13-230276 · Cited by 148
“In particular, resolution of inflammation is now regarded as an active and highly regulated process involving the generation of specialized proresolving lipid mediators (SPMs) that operate as “resolution agonists” to determine the overall magnitude and duration of inflammation (3, 4).”
BackgroundPro-Resolving Mediators in Regulating and Conferring Macrophage Function
Dalli, J., & Serhan, C. N. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01400 · Cited by 146
Self-citationHypothalamic dysfunction in obesity
Williams, L. M. (2012) · Proceedings of the Nutrition Society · doi:10.1017/s002966511200078x · Cited by 146
“Inflammation is normally a transient response to infection or injury and is rapidly resolved to prevent tissue damage and chronic disease((60)).”
BackgroundVieira, A. T., Rocha, V. M., Tavares, L. P., Garcia, C. C., Teixeira, M. M., Oliveira, S. C., Cassali, G. D., Gamba, C. D. O., Martins, F. S., & Nicoli, J. R. (2015) · Microbes and Infection · doi:10.1016/j.micinf.2015.10.008 · Cited by 169
Maksymowych, W. P., Wichuk, S. A., Chiowchanwisawakit, P., Lambert, R. G. W., & Pedersen, S. J. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38792 · Cited by 149
“The return of inflammation to a state of homeostasis is an actively regulated program at the tissue level that has been termed catabasis (27) and is mediated by several novel lipid mediators, which could be related to the appearances on T1-weighted MRI.”
BackgroundEosinophils promote resolution of acute peritonitis by producing proresolving mediators in mice
Yamada, T., Tani, Y., Nakanishi, H., Taguchi, R., Arita, M., & Arai, H. (2011) · The FASEB Journal · doi:10.1096/fj.10-170027 · Cited by 143
“The local inflammatory response is characterized by a sequential release of mediators and the recruitment of different types of leukocytes that become activated at the inflamed site (3, 5).”
BackgroundHydrogen sulfide and nitric oxide interactions in inflammation
Whiteman, M. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.10.021 · Cited by 141
Zhou, Z., Ni, K., Deng, H., & Chen, X. S. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.006 · Cited by 145
McMonnies, C. W. (2015) · Optometry and Vision Science · doi:10.1097/opx.0000000000000455 · Cited by 157
“The inflammatory process can be protective but have deleterious consequences.(52) Cytokines can have both proinflammatory and anti-inflammatory functions.”
BackgroundEVALUATION OF THE ANTI-INFLAMMATORY CAPACITY OF BETA-SITOSTEROL IN RODENT ASSAYS
Paniagua‐Pérez, R., Flores-Mondragón, G., Reyes-Legorreta, C., Herrera-López, B., Cervantes-Hernández, I., Madrigal-Santillán, O., Morales‐González, J. A., Álvarez‐González, I., & Madrigal‐Bujaidar, E. (2016) · African Journal of Traditional Complementary and Alternative Medicines · doi:10.21010/ajtcam.v14i1.13 · Cited by 136
“In the process, a reduction of proinflammatory mediators occur, in addition to the release of pro-resolving mediators which prevents migration of leukocytes and increases their apoptosis (Serhan and Savill, 2005; Serhan et al., 2007).”
BackgroundCakarova, L., Marsh, L. M., Wilhelm, J., Mayer, K., Grimminger, F., Seeger, W., Lohmeyer, J., & Herold, S. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200812-1837oc · Cited by 135
Efferocytosis in atherosclerotic lesions: Malfunctioning regulatory pathways and control mechanisms
Tajbakhsh, A., Rezaee, M., Kovanen, P. T., & Sahebkar, A. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.02.003 · Cited by 134
Cell Death-Associated Molecular-Pattern Molecules: Inflammatory Signaling and Control
Sangiuliano, B., Pérez, N. M., Moreira, D. F., & Belizário, J. E. (2014) · Mediators of Inflammation · doi:10.1155/2014/821043 · Cited by 134
Toll-like receptors in cerebral ischemic inflammatory injury
Wang, Y., Lin, S., & Yang, Q. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-134 · Cited by 141
“The balance between the destructive and protective effects of the innate immune response must be precisely regulated to promote conditions that support brain repair and maintain tissue homeostasis [5].”
BackgroundThe inflammasome in host response to biomaterials: Bridging inflammation and tissue regeneration
Vasconcelos, D. P., Águas, A. P., Barbosa, M. A., Pelegrín, P., & Barbosa, J. N. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.09.056 · Cited by 134
Hallett, J. M., Leitch, A. E., Riley, N. A., Duffin, R., Haslett, C., & Rossi, A. G. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.03.002 · Cited by 134
Self-citationPhysiological and Pathophysiological Roles of Hydrogen Sulfide in the Gastrointestinal Tract
Wallace, J. L. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2900 · Cited by 132
“Resolution of an inflammatory process is complex, involving the removal of infiltrating leukocytes and the repair of tissue injury (39).”
Self-citationNew insights into the resolution of inflammation
Gilroy, D. W., & Maeyer, R. P. H. D. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.05.003 · Cited by 156
Self-citationJan, N., Madni, A., Khan, S., Shah, H., Akram, F., Khan, A., Ertas, D., Bostanudin, M. F., Contag, C. H., Ashammakhi, N. A., et al. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10441 · Cited by 150
Mediator lipidomics in acute inflammation and resolution
Arita, M. (2012) · Journal of Biochemistry · doi:10.1093/jb/mvs092 · Cited by 131
“In healthy individuals, acute inflammation is self-limiting and has an active termination program (2).”
BackgroundDiversity of lipid mediators in human adipose tissue depots
Clària, J., Nguyen, B. T., Madenci, A. L., Ozaki, C. K., & Serhan, C. N. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00351.2012 · Cited by 130
“Since unresolved inflammation is detrimental to the host, higher organisms have evolved protective mechanisms to ensure resolution of the inflammatory response in a specific time-limited manner (28).”
Self-citationFPR2/ALXR Agonists and the Resolution of Inflammation
Corminboeuf, O., & Leroy, X. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501051x · Cited by 139
A Close Encounter of the Third Kind
Mildner, A., Yona, S., & Jung, S. (2013) · Advances in immunology · doi:10.1016/b978-0-12-417028-5.00003-x · Cited by 141
Khan, M. S., Ali, T., Kim, M. W., Jo, M. H., Chung, J. I., & Kim, M. O. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1101-1 · Cited by 138
RetractedResolving an inflammatory concept: The importance of inflammation and resolution in tendinopathy
Dakin, S. G., Dudhia, J., & Smith, R. K. W. (2014) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2014.01.007 · Cited by 133
Prieto, P., Cuenca, J., Través, P. G., Fernández‐Velasco, M., Martín‐Sanz, P., & Boscá, L. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2009.220 · Cited by 132
“The effects of LXs as lipid mediators with potent anti-inflammatory actions are well documented, but their role in apoptosis remains controversial.(9) For instance, an apoptotic effect on fibroblasts after treatment with LXA4 at micromolar concentrations has been described,(10) whereas it has been also reported that t…”
BackgroundTargeting granulocyte apoptosis: mechanisms, models, and therapies
Duffin, R., Leitch, A. E., Fox, S., Haslett, C., & Rossi, A. G. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00922.x · Cited by 124
Self-citationKhan, M. S., Ali, T., Kim, M. W., Jo, M. H., Jo, M. G., Badshah, H., & Kim, M. O. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.08.005 · Cited by 124
Pattison, M. J., MacKenzie, K. F., & Arthur, J. S. C. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200310 · Cited by 123
Interleukin-1β in Central Nervous System Injury and Repair.
Hewett, S. J., Jackman, N. A., & Claycomb, R. (2012) · PubMed · Cited by 189
Macrophage-targeted nanomedicine for chronic diseases immunotherapy
Song, Y., Huang, Y., Zhou, F., Ding, J., & Zhou, W. (2022) · Chinese Chemical Letters · doi:10.1016/j.cclet.2021.08.090 · Cited by 120
Macrophage Proresolving Mediators—the When and Where
Dalli, J., & Serhan, C. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0001-2014 · Cited by 121
Self-citationModulation of Neutrophil Apoptosis and the Resolution of Inflammation through β2 Integrins
El Kebir, D., & Filep, J. G. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00060 · Cited by 121
“Lipoxins stimulate recruitment of monocytes and inhibit neutrophil trafficking and accumulation in inflamed tissues (reviewed in Serhan et al., 2007; Serhan et al., 2008).”
BackgroundLipoxin A 4 and benzo‐lipoxin A 4 attenuate experimental renal fibrosis
Börgeson, E., Docherty, N. G., Murphy, M., Rodgers, K., Ryan, A., O'Sullivan, T. P., Guiry, P. J., Goldschmeding, R., Higgins, D. F., & Godson, C. (2011) · The FASEB Journal · doi:10.1096/fj.11-185017 · Cited by 119
Lee, H., & Surh, Y. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.07.002 · Cited by 129
Macrophage development and polarization in chronic inflammation
Motwani, M. P., & Gilroy, D. W. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.07.002 · Cited by 129
Self-citationCorrection of MFG-E8 Resolves Inflammation and Promotes Cutaneous Wound Healing in Diabetes
Das, A., Ghatak, S., Sinha, M., Chaffee, S. M., Ahmed, N. S., Parinandi, N. L., Wohleb, E. S., Sheridan, J. F., Sen, C. K., & Roy, S. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502270 · Cited by 131
Therapeutic anti-inflammatory potential of formyl-peptide receptor agonists
Dufton, N., & Perretti, M. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.04.010 · Cited by 132
Self-citationJoint pathology and platelet-rich plasma therapies
Andía, I., Sánchez, M., & Maffulli, N. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.632765 · Cited by 131
Conventional dendritic cells regulate the outcome of colonic inflammation independently of T cells
Abe, K., Nguyen, K., Fine, S., Mo, J., Shen, C., Shenouda, S., Corr, M., Jung, S., Lee, J., Eckmann, L., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708469104 · Cited by 125
Lipoxin A 4 attenuates adipose inflammation
Börgeson, E., McGillicuddy, F. C., Harford, K. A., Corrigan, N., Higgins, D. F., Maderna, P., Roche, H. M., & Godson, C. (2012) · The FASEB Journal · doi:10.1096/fj.12-208249 · Cited by 113
“is necessary to ensure tissue homeostasis (5, 6).”
BackgroundResolvin D1 promotes efferocytosis in aging by limiting senescent cell‐induced MerTK cleavage
Rymut, N., Heinz, J., Sadhu, S., Hosseini, Z., Riley, C. O., Marinello, M., Maloney, J., MacNamara, K. C., Spite, M. R., & Fredman, G. (2019) · The FASEB Journal · doi:10.1096/fj.201902126r · Cited by 122
MacDowell, K. S., García-Bueno, B., Madrigal, J. L. M., Parellada, M., Arango, C., Micó, J. A., & Leza, J. C. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001775 · Cited by 114
“In the last few years, a rich database has been developed substantiating the capacity of endogenous counterbalancing mechanisms taking place when an inflammatory or immune stimulus appears (Serhan et al. 2007).”
BackgroundMontero-Melendez, T. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.02.003 · Cited by 113
“[46] Serhan CN, Brain SD, Buckley CD, Gilroy DW, Haslett C, O’Neill LA, et al.”
López‐Vicario, C., Rius, B., Alcaraz‐Quiles, J., García‐Alonso, V., Lopategi, A., Titos, E., & Clària, J. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.092 · Cited by 127
“…74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 inflammation is detrimental to the host, higher organisms have evolved protective mechanisms to ensure resolution of the inflammatory response in a specific time-limited manner (Serhan et al., 2007).”
BackgroundTissue-infiltrating neutrophils represent the main source of IL-23 in the colon of patients with IBD
Kvedaraite, E., Lourda, M., Ideström, M., Chen, P., Olsson‐Åkefeldt, S., Forkel, M., Gavhed, D., Lindforss, U., Mjösberg, J., Henter, J., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-309014 · Cited by 120
Lanosterol Modulates TLR4-Mediated Innate Immune Responses in Macrophages
Araldi, E., Fernández-Fuertes, M., Canfrán-Duque, A., Tang, W., Cline, G. W., Madrigal-Matute, J., Pober, J. S., Lasunción, M. A., Wu, D., Fernández-Hernando, C., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.093 · Cited by 112
“Thus, to avoid excess inflammation and tissue damage, it is important that the production of proinflammatory cytokines is kept under control (Serhan et al., 2007).”
Neutrophil interactions with epithelial-expressed ICAM-1 enhances intestinal mucosal wound healing
Sumagin, R., Brazil, J. C., Nava, P., Nishio, H., Alam, A. M., Luissint, A., Weber, D. A., Neish, A. S., Nusrat, A., & Parkos, C. A. (2016) · Mucosal Immunology · doi:10.1038/mi.2015.135 · Cited by 116
PGD Synthase and PGD 2 in Immune Resposne
Joo, M., & Sadikot, R. T. (2012) · Mediators of Inflammation · doi:10.1155/2012/503128 · Cited by 126
“The importance of the role of PGD2 in the pathogenesis and resolution of inflammation and innate immune response is increasingly recognized [6, 7].”
BackgroundPrüss, H., Kopp, M. A., Brommer, B., Gatzemeier, N., Laginha, I., Dirnagl, U., & Schwab, J. M. (2011) · Brain Pathology · doi:10.1111/j.1750-3639.2011.00488.x · Cited by 110
“Resolution is already encoded at the onset of inflammation and includes suppression of further leukocyte influx and clearance of inflammatory cells, suppression of pro-inflammatory factors and release of pro-resolving factors (14, 44).”
BackgroundInfluentialGaseous mediators in resolution of inflammation
Wallace, J. L., Ianaro, A., Flannigan, K. L., & Cirino, G. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.05.004 · Cited by 109
Self-citationKey mechanisms involved in ionizing radiation-induced systemic effects. A current review
Mavragani, I. V., Laskaratou, D., Frey, B., Candéias, S. M., Gaipl, U. S., Lumniczky, K., & Georgakilas, A. G. (2015) · Toxicology Research · doi:10.1039/c5tx00222b · Cited by 123
Resolvins: Natural agonists for resolution of pulmonary inflammation
Uddin, M., & Levy, B. D. (2010) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.09.002 · Cited by 126
“As our understanding of the cellular and molecular mechanisms of inflammation has evolved, it has become apparent that anti-inflammation and pro-resolution are distinct physiological processes [31].”
BackgroundAnesthetics Impact the Resolution of Inflammation
Chiang, N., Schwab, J. M., Fredman, G., Kasuga, K., Gelman, S., & Serhan, C. N. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001879 · Cited by 109
“, aspirin-triggered epimer of lipoxin A4 [ATL] and resolvin E1), promotes resolution [4,9].”
BackgroundSelf-citationResolvin E1 Regulates Adenosine Diphosphate Activation of Human Platelets
Fredman, G., Van Dyke, T. E., & Serhan, C. N. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.209908 · Cited by 108
Self-citationAlvarado-Vazquez, P. A., Bernal, L., Paige, C. A., Grosick, R. L., Moracho Vilrriales, C., Ferreira, D. W., Ulecia-Morón, C., & Romero-Sandoval, E. A. (2017) · Immunobiology · doi:10.1016/j.imbio.2017.05.011 · Cited by 108
Spinal cord regeneration: Lessons for mammals from non‐mammalian vertebrates
Lee‐Liu, D., Edwards‐Faret, G., Tapia, V. S., & Larraín, J. (2013) · genesis · doi:10.1002/dvg.22406 · Cited by 108
“Resolution of inflammation is histologically defined as the interval between maximum cell infiltration and the moment it is completely lost from the tissue (Serhan et al., 2007).”
Background
Metadata
- Authors
- Serhan, C. N., Brain, S. D., Buckley, C. D., Gilroy, D. W., Haslett, C., O'Neill, L. A. J., Perretti, M., Rossi, A. G., & Wallace, J. L.
- Affiliations
- Brigham and Women's Hospital (US)
- King's College London (GB)
- University of Birmingham (GB)
- University College London (GB)
- Centre for Inflammation Research (GB)
- Trinity College Dublin (IE)
- Queen Mary University of London (GB)
- University of Calgary (CA)
- Corresponding author
- Serhan, Charles N.
- ORCID
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2007-02
- Volume
- 21
- Issue
- 2
- Pages
- 325-332
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- PMC
- PMC3119634
- OpenAlex
- W2120699390
- Cited by
- 1,045
- References
- 36
- Citations by year
- 2026: 20 · 2025: 26 · 2024: 30 · 2023: 46 · 2022: 42 · 2021: 59 · 2020: 70 · 2019: 53 · 2018: 57 · 2017: 59 · 2016: 57 · 2015: 66 · 2014: 65 · 2013: 90 · 2012: 74
- FWCI
- 6.67
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- Norges Idrettshøgskole
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- inflammation resolution, acute inflammation, anti-inflammatory agents, inflammation-associated diseases
- MeSH terms
- Animals, Anti-Inflammatory Agents, Humans, Inflammation, Leukocytes, Models, Biological, Cytokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.